BioSpace News Archive

Business

Solarvest Elects New Board of Directors

Solarvest BioEnergy Inc. (TSXV: SVS.H) (“Solarvest”, or the “Company”), an algal biologic company specializing in organic ingredient production

June 7, 2024
·
4 min read
Biotech Bay

Kyverna Therapeutics to Present Data on 50 Patient Experience at Symposium at EULAR 2024

Kyverna Therapeutics, Inc. announced today that it will host a sponsored symposium to present the largest and most diverse set of data to date from a cohort of 50 patients treated with the CAR in KYV-101, an autologous, fully human anti-CD19 CAR T-cell immunotherapy.

June 7, 2024
·
5 min read
NervGen Pharma Grants Stock Options.

NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that the company has granted 950,000

June 7, 2024
·
1 min read
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

NeurAxis, Inc. today announced a submission to the FDA for expansion of its IB-Stim label. The new submission is significant as it would allow access to a larger patient population beyond 11-18 years of age and allow for marketing of 4 devices per prescription.

June 7, 2024
·
5 min read
Potential Add-on Treatment for Patients with Parkinson’s Disease: Stimvia Completes Pilot Study and Announces Promising Initial Results

Stimvia, a pioneering medical technology company specializing in neuromodulation for chronic disease treatment, has successfully completed its pilot study focused on Parkinson’s Disease and is expecting promising results.

June 7, 2024
·
2 min read
Biotech Bay

BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2024 Congress

BioMarin Pharmaceutical Inc. will be presented at the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Bangkok, Thailand, June 22-26, 2024.

June 7, 2024
·
15 min read
Biotech Bay

Helix Launches Clinico-Genomic Datasets for Cardiovascular, Metabolic, Immunology and Inflammation Disorders

Helix , the leading population genomics company, is launching new clinico-genomic datasets to enable life science companies to drive precision medicine drug discovery and development.

June 7, 2024
·
2 min read
Biotech Beach

ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update

ImmunityBio, Inc. ( NASDAQ: IBRX ) announced today that its 2024 Annual Meeting of Stockholders will be held on Tuesday, June 11, 2024 at 9:30 a.m. Pacific Time.

June 7, 2024
·
6 min read
Biotech Beach

Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference

Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference.

June 7, 2024
·
7 min read
Genetown

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2024-2025 formula, targeting the SARS-CoV-2 variant JN.1.

June 7, 2024
·
5 min read